Name: #657: Great Science Isn’t Enough: Building Value Early in Emerging Biotech
Start: 2026-06-17T16:00:00-0400
End: 2026-06-17T17:15:00-0400

#657: Great Science Isn’t Enough: Building Value Early in Emerging Biotech

Wednesday June 17, 2026 4:00pm - 5:15pm EDT

103A

Component Type: Session
Level: Intermediate

As a closing session, this discussion brings together key themes from the day to examine how innovators can better connect science to market realities. It will highlight practical ways to optimize product value for investors, payers, and regulators

Learning Objectives

Understand the factors that shape product value; Identify critical early decisions (indication, endpoints, evidence) that influence downstream access and partnering outcomes; Define opportunities to better align development strategy with payer, provider, and investor expectations.

Chair

Mark Twyman

Speaker

Panelist
Michael Kuchenreuther

Speakers

Michael Kuchenreuther

Director Research & Analytics, Numerof & Associates, United States

Mark Twyman

Senior Consultant & Engagement Manager, Numerof & Associates, United States

Wednesday June 17, 2026 4:00pm - 5:15pm EDT
103A The Pennsylvania Convention Center 1101 Arch Street Philadelphia, PA 19107 USA

09: RD-Quality-Compliance, Session | 18: Lift-Series, Session

Audience Intermediate
Area Biotech-ClinTech-Pathway
Level Intermediate
format csv
Interest Area Biotechnology & Investors
Feature Topics Biotech-ClinTech-Pathway
Tags Session

Success you have shared X tickets.

DIA 2026 Global Annual Meeting

Michael Kuchenreuther

Mark Twyman

Get help with the event

Success you have shared X tickets.

DIA 2026 Global Annual Meeting

Michael Kuchenreuther

Mark Twyman

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

Get help with the event